Dry Powder Inhalers Market
Dry Powder Inhalers Market Forecasts to 2030 - Global Analysis By Product (Multi Dose Dry Powder Inhalers and Single Dose Dry Powder Inhalers), Function, Indication, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $21.48 BN |
|
Projected Year Value (2030) |
US $33.60 BN |
|
CAGR (2023 - 2030) |
6.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Dry Powder Inhalers Market is accounted for $21.48 billion in 2023 and is expected to reach $33.60 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Dry powder inhalers are medical devices that inhale powdered medication directly into the lungs. For the treatment of lung-related disorders and respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), they are frequently prescribed. They don't need propellants to deliver the medication, in contrast to metered-dose inhalers (MDIs) and are also appropriate for people who might have trouble using MDIs because they do not require hand-breath coordination.
According to the article titled ""Common Respiratory Disorders” published in April 2020 around 15% of older adults from asthma, chronic obstructive pulmonary disease, or another respiratory disorder.
Market Dynamics:
Driver:
Rising prevalence of respiratory disorders
The increasing prevalence of respiratory ailments such as cystic fibrosis, bronchitis, asthma, and chronic obstructive pulmonary disease (COPD) directly drives the need for efficient inhalation therapies. Since dry powder inhalers provide a practical and effective means of delivering medication directly to the lungs, they are in high demand as a treatment modality for these conditions. The increasing number of people suffering from respiratory disorders has led to a greater focus on symptom management, averting exacerbations, and enhancing overall disease management and these are used more frequently because of their critical role in sustaining long-term symptom control and offering immediate relief which drives the growth of the market.
Restraint:
High production costs and difficulty in application
Medication noncompliance brought on by difficulties managing the condition may lead to insufficient therapy, worsening of the illness, and higher medical expenses. If patients find Dry powder inhalers difficult to handle or load, they may choose to use alternative inhaler devices like nebulizers or metered-dose inhalers (MDIs). The market share and sales of dry powder inhalers may be impacted by this change in preferences. It may be necessary for healthcare providers to devote additional time and resources to instructing patients on proper handling and loading techniques. The complexity of patient education programs may increase due to this additional training requirement, which may also raise healthcare costs thus hamper the growth of the market.
Opportunity:
Increased focus on preventive care and disease management
Healthcare systems and providers are encouraged to concentrate on early intervention strategies due to the increased emphasis on preventive care. By offering prophylactic medication to manage symptoms and stop exacerbations and they contribute significantly to the management of respiratory conditions. Patient-centric care models are becoming more and more important as the focus shifts to illness prevention and management. Dry powder inhalers complement these care models by empowering patients to actively manage their respiratory conditions because they are easy to use and appropriate for self-administration.
Threat:
Availability of raw materials with intense competition
Insufficient compliance with drug regimens, such as dry powder inhalers, may result in insufficient treatment of respiratory disorders like COPD or asthma. Reduced lung function, an increase in the frequency of exacerbations, worsening symptoms, and an increased risk of hospitalization can all be caused by incomplete or irregular dosing. Moreover, demand of patient preferences, and prescription rates may all be impacted if patients fail to comply for a variety of reasons, such as inhaler difficulties. This might result in having a smaller market share than other kinds of inhalers.
Covid-19 Impact
Demand for respiratory medications, including those given through DPIs, surged during the pandemic as a result of increased awareness of respiratory health and worries about lung health brought on by COVID-19. Patients with long-term respiratory disorders tried to get access to the drugs they needed and continue their treatment plans. There was a move toward at-home medication self-administration due to limitations on mobility and visits to medical facilities. Due to their self-administration capabilities and ease of use, DPIs have become the go-to choice for treating respiratory disorders when regular clinic visits are not feasible.
The multi dose dry powder inhalers segment is expected to be the largest during the forecast period
The multi dose dry powder inhalers segment is estimated to have a lucrative growth, as they are used to administer powdered medication directly into the lungs. They usually use a reservoir that holds multiple doses of the powdered medication, allowing patients to take multiple doses over time. They enable the device to be preloaded with multiple doses, giving patients dosage flexibility and the ability to take their recommended doses at predetermined intervals. In order to meet patient needs and enhance treatment outcomes, manufacturers in this market sector are constantly innovating, concentrating on bettering drug delivery systems, ergonomics of devices, and dose accuracy.
The digitally operated inhaler devices segment is expected to have the highest CAGR during the forecast period
The digitally operated inhaler devices segment is anticipated to witness the highest CAGR growth during the forecast period, because digitally operated inhaler devices are a new and creative segment. Digital technology in these inhalers enables improved features like data tracking, connectivity, and better patient adherence to prescription schedules. Thus, the goal of adding digital components to inhaler devices is to enhance the way respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma are managed. Because digitally operated inhalers collect data on individual patient responses to treatment and inhaler usage patterns, they can support personalized medicine approaches thus boosting the growth of the market.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the as a result of numerous government programs and healthcare regulations targeted at enhancing respiratory health and illness management. Adoption of DPIs and other effective inhalation therapies is frequently encouraged by supportive policies. Patient adherence and management are improved by the combination of DPIs with digital technologies, such as smart inhalers that provide features like dose tracking, reminders, and connectivity. The evolution of the market is driven by this patient-centric approach.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to the incidence of respiratory conditions such as asthma and COPD has been increasing, which has increased the need for efficient inhalation treatments. DPIs provide a practical and effective means of administering medicine to treat these ailments. Moreover, the market has grown as a result of ongoing innovations in drug delivery systems, formulations, and DPI designs. To increase medication adherence and efficacy, manufacturers are always working to create DPIs that are more portable, user-friendly, and efficient.
Key players in the market
Some of the key players profiled in the Dry Powder Inhalers Market include GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Cipla Limited, Chiesi Farmaceutici S.p.A, AptarGroup, Inc., Iconovo AB, Mylan N.V, Pharmaxis, Teva Pharmaceutical Industries Limited, AstraZeneca Plc, Novartis AG, Elpen S.A, Vectura Group Plc, Beximco Pharmaceuticals Ltd, Hovione, MannKind Corporation, Sava Healthcare Ltd, 3M Company and DPI Co., Ltd.
Key Developments:
In October 2023, GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen. There is high unmet need in CHB with an estimated 300 million people living with the disease and a less than 3-7% functional cure rate with current treatment options.
In October 2023, GSK launches £6m programme to boost STEM career progression for young people from under-represented groups in the UK. New research reveals a nationwide focus on STEM mentoring of under-represented groups could boost individual incomes.
In October 2023, Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss. The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms, and the development of treatments to detect early and treat retinal diseases before irreversible loss of vision occurs
Products Covered:
• Multi Dose Dry Powder Inhalers
• Single Dose Dry Powder Inhalers
Functions Covered:
• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices
Indications Covered:
• Pulmonary Arterial Hypertension
• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Cystic Fibrosis
End Users Covered:
• Drug Stores
• Retail Pharmacies
• Hospitals
• Online Pharmacies
• Ambulatory Surgical Centers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Dry Powder Inhalers Market, By Product
5.1 Introduction
5.2 Multi Dose Dry Powder Inhalers
5.3 Single Dose Dry Powder Inhalers
6 Global Dry Powder Inhalers Market, By Function
6.1 Introduction
6.2 Manually Operated Inhaler Devices
6.3 Digitally Operated Inhaler Devices
7 Global Dry Powder Inhalers Market, By Indication
7.1 Introduction
7.2 Pulmonary Arterial Hypertension
7.3 Chronic Obstructive Pulmonary Disease (COPD)
7.4 Asthma
7.5 Cystic Fibrosis
8 Global Dry Powder Inhalers Market, By End User
8.1 Introduction
8.2 Drug Stores
8.3 Retail Pharmacies
8.4 Hospitals
8.5 Online Pharmacies
8.6 Ambulatory Surgical Centers
8.7 Other End Users
9 Global Dry Powder Inhalers Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 GlaxoSmithKline Plc
11.2 Boehringer Ingelheim GmbH
11.3 Cipla Limited
11.4 Chiesi Farmaceutici S.p.A
11.5 AptarGroup, Inc.
11.6 Iconovo AB
11.7 Mylan N.V
11.8 Pharmaxis
11.9 Teva Pharmaceutical Industries Limited
11.10 AstraZeneca Plc
11.11 Novartis AG
11.12 Elpen S.A
11.13 Vectura Group Plc
11.14 Beximco Pharmaceuticals Ltd
11.15 Hovione
11.16 MannKind Corporation
11.17 Sava Healthcare Ltd
11.18 3M Company
11.19 DPI Co., Ltd.
List of Tables
1 Global Dry Powder Inhalers Market Outlook, By Region (2021-2030) ($MN)
2 Global Dry Powder Inhalers Market Outlook, By Product (2021-2030) ($MN)
3 Global Dry Powder Inhalers Market Outlook, By Multi Dose Dry Powder Inhalers (2021-2030) ($MN)
4 Global Dry Powder Inhalers Market Outlook, By Single Dose Dry Powder Inhalers (2021-2030) ($MN)
5 Global Dry Powder Inhalers Market Outlook, By Function (2021-2030) ($MN)
6 Global Dry Powder Inhalers Market Outlook, By Manually Operated Inhaler Devices (2021-2030) ($MN)
7 Global Dry Powder Inhalers Market Outlook, By Digitally Operated Inhaler Devices (2021-2030) ($MN)
8 Global Dry Powder Inhalers Market Outlook, By Indication (2021-2030) ($MN)
9 Global Dry Powder Inhalers Market Outlook, By Pulmonary Arterial Hypertension (2021-2030) ($MN)
10 Global Dry Powder Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
11 Global Dry Powder Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
12 Global Dry Powder Inhalers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
13 Global Dry Powder Inhalers Market Outlook, By End User (2021-2030) ($MN)
14 Global Dry Powder Inhalers Market Outlook, By Drug Stores (2021-2030) ($MN)
15 Global Dry Powder Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
16 Global Dry Powder Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
17 Global Dry Powder Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
18 Global Dry Powder Inhalers Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
19 Global Dry Powder Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
20 North America Dry Powder Inhalers Market Outlook, By Country (2021-2030) ($MN)
21 North America Dry Powder Inhalers Market Outlook, By Product (2021-2030) ($MN)
22 North America Dry Powder Inhalers Market Outlook, By Multi Dose Dry Powder Inhalers (2021-2030) ($MN)
23 North America Dry Powder Inhalers Market Outlook, By Single Dose Dry Powder Inhalers (2021-2030) ($MN)
24 North America Dry Powder Inhalers Market Outlook, By Function (2021-2030) ($MN)
25 North America Dry Powder Inhalers Market Outlook, By Manually Operated Inhaler Devices (2021-2030) ($MN)
26 North America Dry Powder Inhalers Market Outlook, By Digitally Operated Inhaler Devices (2021-2030) ($MN)
27 North America Dry Powder Inhalers Market Outlook, By Indication (2021-2030) ($MN)
28 North America Dry Powder Inhalers Market Outlook, By Pulmonary Arterial Hypertension (2021-2030) ($MN)
29 North America Dry Powder Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
30 North America Dry Powder Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
31 North America Dry Powder Inhalers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
32 North America Dry Powder Inhalers Market Outlook, By End User (2021-2030) ($MN)
33 North America Dry Powder Inhalers Market Outlook, By Drug Stores (2021-2030) ($MN)
34 North America Dry Powder Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
35 North America Dry Powder Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
36 North America Dry Powder Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
37 North America Dry Powder Inhalers Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
38 North America Dry Powder Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
39 Europe Dry Powder Inhalers Market Outlook, By Country (2021-2030) ($MN)
40 Europe Dry Powder Inhalers Market Outlook, By Product (2021-2030) ($MN)
41 Europe Dry Powder Inhalers Market Outlook, By Multi Dose Dry Powder Inhalers (2021-2030) ($MN)
42 Europe Dry Powder Inhalers Market Outlook, By Single Dose Dry Powder Inhalers (2021-2030) ($MN)
43 Europe Dry Powder Inhalers Market Outlook, By Function (2021-2030) ($MN)
44 Europe Dry Powder Inhalers Market Outlook, By Manually Operated Inhaler Devices (2021-2030) ($MN)
45 Europe Dry Powder Inhalers Market Outlook, By Digitally Operated Inhaler Devices (2021-2030) ($MN)
46 Europe Dry Powder Inhalers Market Outlook, By Indication (2021-2030) ($MN)
47 Europe Dry Powder Inhalers Market Outlook, By Pulmonary Arterial Hypertension (2021-2030) ($MN)
48 Europe Dry Powder Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
49 Europe Dry Powder Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
50 Europe Dry Powder Inhalers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
51 Europe Dry Powder Inhalers Market Outlook, By End User (2021-2030) ($MN)
52 Europe Dry Powder Inhalers Market Outlook, By Drug Stores (2021-2030) ($MN)
53 Europe Dry Powder Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
54 Europe Dry Powder Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
55 Europe Dry Powder Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
56 Europe Dry Powder Inhalers Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
57 Europe Dry Powder Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
58 Asia Pacific Dry Powder Inhalers Market Outlook, By Country (2021-2030) ($MN)
59 Asia Pacific Dry Powder Inhalers Market Outlook, By Product (2021-2030) ($MN)
60 Asia Pacific Dry Powder Inhalers Market Outlook, By Multi Dose Dry Powder Inhalers (2021-2030) ($MN)
61 Asia Pacific Dry Powder Inhalers Market Outlook, By Single Dose Dry Powder Inhalers (2021-2030) ($MN)
62 Asia Pacific Dry Powder Inhalers Market Outlook, By Function (2021-2030) ($MN)
63 Asia Pacific Dry Powder Inhalers Market Outlook, By Manually Operated Inhaler Devices (2021-2030) ($MN)
64 Asia Pacific Dry Powder Inhalers Market Outlook, By Digitally Operated Inhaler Devices (2021-2030) ($MN)
65 Asia Pacific Dry Powder Inhalers Market Outlook, By Indication (2021-2030) ($MN)
66 Asia Pacific Dry Powder Inhalers Market Outlook, By Pulmonary Arterial Hypertension (2021-2030) ($MN)
67 Asia Pacific Dry Powder Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
68 Asia Pacific Dry Powder Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
69 Asia Pacific Dry Powder Inhalers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
70 Asia Pacific Dry Powder Inhalers Market Outlook, By End User (2021-2030) ($MN)
71 Asia Pacific Dry Powder Inhalers Market Outlook, By Drug Stores (2021-2030) ($MN)
72 Asia Pacific Dry Powder Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
73 Asia Pacific Dry Powder Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
74 Asia Pacific Dry Powder Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
75 Asia Pacific Dry Powder Inhalers Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
76 Asia Pacific Dry Powder Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
77 South America Dry Powder Inhalers Market Outlook, By Country (2021-2030) ($MN)
78 South America Dry Powder Inhalers Market Outlook, By Product (2021-2030) ($MN)
79 South America Dry Powder Inhalers Market Outlook, By Multi Dose Dry Powder Inhalers (2021-2030) ($MN)
80 South America Dry Powder Inhalers Market Outlook, By Single Dose Dry Powder Inhalers (2021-2030) ($MN)
81 South America Dry Powder Inhalers Market Outlook, By Function (2021-2030) ($MN)
82 South America Dry Powder Inhalers Market Outlook, By Manually Operated Inhaler Devices (2021-2030) ($MN)
83 South America Dry Powder Inhalers Market Outlook, By Digitally Operated Inhaler Devices (2021-2030) ($MN)
84 South America Dry Powder Inhalers Market Outlook, By Indication (2021-2030) ($MN)
85 South America Dry Powder Inhalers Market Outlook, By Pulmonary Arterial Hypertension (2021-2030) ($MN)
86 South America Dry Powder Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
87 South America Dry Powder Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
88 South America Dry Powder Inhalers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
89 South America Dry Powder Inhalers Market Outlook, By End User (2021-2030) ($MN)
90 South America Dry Powder Inhalers Market Outlook, By Drug Stores (2021-2030) ($MN)
91 South America Dry Powder Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
92 South America Dry Powder Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
93 South America Dry Powder Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
94 South America Dry Powder Inhalers Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
95 South America Dry Powder Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
96 Middle East & Africa Dry Powder Inhalers Market Outlook, By Country (2021-2030) ($MN)
97 Middle East & Africa Dry Powder Inhalers Market Outlook, By Product (2021-2030) ($MN)
98 Middle East & Africa Dry Powder Inhalers Market Outlook, By Multi Dose Dry Powder Inhalers (2021-2030) ($MN)
99 Middle East & Africa Dry Powder Inhalers Market Outlook, By Single Dose Dry Powder Inhalers (2021-2030) ($MN)
100 Middle East & Africa Dry Powder Inhalers Market Outlook, By Function (2021-2030) ($MN)
101 Middle East & Africa Dry Powder Inhalers Market Outlook, By Manually Operated Inhaler Devices (2021-2030) ($MN)
102 Middle East & Africa Dry Powder Inhalers Market Outlook, By Digitally Operated Inhaler Devices (2021-2030) ($MN)
103 Middle East & Africa Dry Powder Inhalers Market Outlook, By Indication (2021-2030) ($MN)
104 Middle East & Africa Dry Powder Inhalers Market Outlook, By Pulmonary Arterial Hypertension (2021-2030) ($MN)
105 Middle East & Africa Dry Powder Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
106 Middle East & Africa Dry Powder Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
107 Middle East & Africa Dry Powder Inhalers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
108 Middle East & Africa Dry Powder Inhalers Market Outlook, By End User (2021-2030) ($MN)
109 Middle East & Africa Dry Powder Inhalers Market Outlook, By Drug Stores (2021-2030) ($MN)
110 Middle East & Africa Dry Powder Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
111 Middle East & Africa Dry Powder Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
112 Middle East & Africa Dry Powder Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
113 Middle East & Africa Dry Powder Inhalers Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
114 Middle East & Africa Dry Powder Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
